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Abstract
Chronic obstructive pulmonary disease (COPD) is an important cause ofmorbidity and disability.Many studies have in-
vestigated factors influencing quality of life (QoL) inmiddle-aged COPD sufferers, but little attention has been given to
elderly COPD.The aim of the present study was to investigate the impact of COPD on QoL and functional status in the
elderly. Sixty COPD patients and 58 healthy controls over 65 years old were administered Pulmonary FunctionTests,
6 minWalkingTest (6MWD) for exercise tolerance, the Barthel Index and Mini Mental State Examination (MMSE) for
functional status, the Geriatric Depression Scale (GDS) for mood, and the Saint George Respiratory Questionnaire
(SGRQ) for QoL.FEV1and PaO2 were reduced in COPD patients. Also the distance walked during 6MWDwas signifi-
cantly shorter for patients than controls (282.5789.5 vs. 332.9795.2m; Po0.01).Moreover,COPD patients had signifi-
cantly worse outcomes for the Barthel Index,GDS and SGRQ. The logistic regression model demonstrated that a
decrease in FEV1 is the factor most strictly related to the deterioration of QoL in COPD patients. Mood was also an
independent factor influencing QoL. In conclusion, elderly COPD patients show a substantial impairment in QoL de-
pending on the severity of airway obstruction; symptoms related to the disease may be exaggerated by mood
deflection. r2003 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2003.1488, available online athttp://www.sciencedirect.com
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Chronic obstructive pulmonary disease (COPD) is ama-
jor cause ofmorbidity in old age, a¡ecting approximately
16% of people over the age of 65 (1).
Progressive improvement in treatment, in particular
the availability of long-term oxygen therapy, has in-
creased the life-expectancy of COPD patients, extend-
ing the interval between onset of disability and death.
Consequently,COPDpatients can survive for a long time
in spite of severe respiratory impairment and disability,
both of which can be assessed by the degree of stable
oxyhaemoglobin desaturation (2).
Elderly patients a¡ected with COPD-related respira-
tory failure are frequently impaired in their social life,
psychic function and activities of daily living (ADL) (3);Received12 Jun 2002; Accepted in revised form18 Nov 2002
Correspondence should be addressed to.Dr.G. Sergi Ospedale
GeriatricoF Clinica Geriatrica, viaVendramini 7, 35100 Padova, Italy.
Fax: +39-49-8216114
E-mail address: giuseppe.sergi@tin.ittherefore, it is of crucial importance to establish the
relationship between COPD and quality of life (QoL) in
this population.
Previous studies reported that respiratory symptoms,
self-perceived health status, cognitive status and mood
can in£uence QoL in COPD; (4^6) nevertheless, even
though the role of these factors has been investigated in
middle-aged patients, little attention has been given to
its analysis in elderly subjects.
The evaluation of health status by separately investi-
gating various physical, cognitive and a¡ective domains
is a common practice in geriatric assessment; more re-
cently, however, a di¡erent approach based on the appli-
cation of disease-speci¢c questionnaires has been
proposed.The Saint George Respiratory Questionnaire
(SGRQ) is a standardizedquestionnaire designed tomea-
suredQoL inpatientswith chronic air£ow limitation and
to quantify the impact of chronic airway obstruction on
health andwell-being (7).
Having taken into account these considerations,
we carried out a study aimed at understanding the
COPDINTHEELDERLY:FUNCTIONALSTATUSANDQUALITYOFLIFE 613impact of chronic airway obstruction on QoL, physical
activity and functional status in elderly patients with
COPD.
METHODS
Subjects
A total of 118 males over 65 years of age were studied.
Sixty were a¡ected with COPD diagnosed on the basis
of respiratory functional impairment measured accord-
ing to the European Respiratory Society criteria (8).
COPD patients were recruited consecutively as outpati-
ents at the geriatric day-hospital during a regular check-
up visit when theymet the inclusion criteria.
Fifty-eighthealthyelderly subjectswere evaluated as a
control group and were recruited consecutively, from
the subjects admitted to our department for a clinical
routine examination.
Exclusion criteria for all subjects were the following:
underweight condition (Body Mass Index (BMI)o18.5)
or obesity (BMI430); ischaemic heart disease; severe li-
ver and renal failure and/or any other acute disease;
changes in medication during the last 30 days and hospi-
tal admission in the previous 6 weeks. Subjects with cog-
nitive, sensory and physical impairment relevant enough
to preclude the execution of pulmonary function
and/or exercise performance tests were also excluded.
The study design was approved by the Ethical Commit-
tee of the University of Padua and the patients and
controls gave their informed consent to participate in
the study.
Study design
All subjects underwent anthropometric measurements,
lung function tests, exercise tolerance evaluation and
multidimensional assessment.
Anthropometricmeasurements
Body weight was measured on a balance beam platform
scale to the nearest 0.1kg. Height was taken by a stadi-
ometer to the nearest centimetre with the subject
standing barefoot, his feet together, at his head level.
BMI was then calculated as body weight (kg) divided by
the square of body height (m2).
Pulmonary function tests
Lung function measurements were evaluated by a com-
puterizedwater-sealed Stead-Wells spirometer (BAIRES
System, Biomedin, Padua, Italy), which ful¢ls the 1994
ATS recommendations for diagnostic spirometry. The
customized software assists the operator during the
test and allows on-line control of compliance with ATScriteria by displaying all the parameters relevant to
the start- and end-of-test, as well as those relevant to
reproducibility of FEV1 and FVC (9). An arterial blood
sample was drawn from the radial artery for blood gas
analysis of PaO2 and PaCO2 (ABL 300 bloodgas analyzer,
Radiometer,Copenhagen,Denmark).
Three days after the check-up, the patients’ oxyhae-
moglobin saturation (SaO2) was recorded continuously
during sleep for at least 8 consecutive hours at home,
using a portable pulso-oximeter (8500A,NoninMedical
Inc.Plymouth,USA).The desaturation index was de¢ned
as the time spent at SaO2o90%.
Exercise performance was evaluated by a 6min Walk-
ingTest (6MWD) according to Guyatt et al. (10). Patients
were asked towalk as far as possible in 6min in a hospital
corridor 100m long. They could determine their own
pace, even stop if necessary, and they were instructed
that at the end they should feel as though they could
not have walked any further. No encouragement during
the test was given. As learning e¡ects have been noticed
to occur quickly with repeated walking tests, the pa-
tients performed one practice 6min test (10). Both the
distance walked and the minimum SaO2 value during
exercisewere evaluated.
Multidimensional assessment
Each patient was asked to complete the following ¢ve
questionnaires: the Barthel Index, the Mini Mental State
Examination (MMSE), the Geriatric Depression Scale
(GDS), the Medical Research Council (MRC) Dyspnoea
Scale and the SGRQ. All the questionnaires were admi-
nistered by trained investigators.
The Barthel Index is based upon an ordinal scale that
evaluates feeding, bathing, grooming, dressing, bladder
control, toileting, chair/bed transfer, mobility and stair
climbing. Subjects are classi¢ed by a score ranging from
0 (complete dependence) to 100 (complete indepen-
dence) (11).
The MMSE is a common test usually administered
for screening dementia. It includes 30 items and yields
a score ranging from 0 to 30; a score lower than 24 is
suggestive of signi¢cant cognitive deterioration (12).
The GDS has 15 items with a score ranging from 0 to
15; a value45 indicates a signi¢cant mood disturbance
(13).
The MRCDyspnoea Scale concerns perceived breath-
lessness and consists of ¢ve degrees: 1, ‘‘shortness of
breath with strenuous exercise’’; 2, ‘‘shortness of breath
when hurrying’’; 3,‘‘walking slower than people of same
age’’; 4,‘‘needing to stop after walking 100 yards on level
ground’’; 5, ‘‘too breathless to leave the house’’ (14). An
Italian translation of MRC Dyspnoea Scale was adminis-
tered to the subjects.
The SGRQis a questionnairevalidatedin order tomea-
sure QoL in subjects with chronic airway obstruction
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components: Symptoms, which measures frequency
and severity of respiratory symptoms; Activity, which
focuses on physical activities that either cause or are
limited by dyspnoea; Impacts, which quanti¢es the
impact of the respiratory disease on the daily life by
assessing psychological problems, need of care, adverse
drug reactions, expectations for health, and distur-
bances of daily life.
Each item of questionnaire has a weight that has been
derived empirically. Because of weights of individual
items, each section of the questionnaire is scored be-
tween 0 (no impairment) and100 (maximal impairment);
a cumulative score for the whole questionnaire is also
computed and ranges between 0 and100 (7,16). A trans-
latedversion of questionnairevalidated for Italy hasbeen
used (17).
Statistical analysis
Datawere analysedusing Systat statistical software,ver-
sion 8.01 for Windows (SPSS Inc.Chicago). Results were
expressed as mean7standard deviation. For anthropo-
metric measures, range and percentiles 25th, 50th, and
75th were also shown. Di¡erences between values of
continuous variables were evaluated by Student’s un-
paired two-sided t-test. The level of statistical signi¢-
cancewas set at Po0.05.
Pearson’s linear correlations was used to examine the
relationship between lung function variables and test
scores.
Logistic regression analysis was performed to de¢ne
the role of independent factors on dependent dichoto-
mous variables as MRC Dyspnoea Scale and QoL ex-
pressed by SGRQ ‘‘Total score’’, with a CI of 95%. The
501 percentile in the distribution of the MRC DyspnoeaTABLE 1. Means values (7SD), range, andpercentiles in anthrop
COPD
Mean (SD) (range) Percentile
25th 50th 75
Age 74.575.8 69 74
(65^87)
Height 167.076.0 162 167 1
(158^177)
Weight 69.2714.2 62 68
(47^94)
BMI 25.173.8 21 24
19.1^29.9
Unpaired t-test. COPD vs.Controls:Pnot signi¢cant.Scale score and SGRQ ‘‘Total score’’ were selected as
cut-o¡ values to represent these dependent dicotomous
variables.
RESULTS
Anthropometric characteristics of subjects are re-
ported inTable1; age and BMI were similar in COPD and
controls. Spirometric and blood gas values of the COPD
patients and normal subjects are reported inTable 2. As
expected, spirometric values (FEV1, FEV1% pred, FEV1/
VC) were signi¢cantly lower for COPD patients than
for the control group.COPD subjectsweremore hypox-
aemic, and hypercapnic than controls.
The Desaturation Index was signi¢cantly higher
among COPD patients than in controls (87.37134.4 vs.
32.1775.7min; Po0.05). Daytime PaO2 inversely corre-
latedwith the Desaturation Index (r 0.59, Po0.001).
Both the 6MWD distance (282.5789.5 vs.
332.9795.2m; Po0.01) and the minimum SaO2 value
during 6MWD (89.175.2 vs. 94.172.0 %; Po0.01) were
signi¢cantly lower for COPD patients than for healthy
subjects.
The data reported in Table 2 also demonstrate that
COPD patients have signi¢cantly worse outcomes con-
cerning the Barthel Index and the GDS and MRC Dys-
pnoea scales; no signi¢cant di¡erence was found
concerning MMSE.
With regard to SGRQ, the total and single section
scores were signi¢cantly higher among COPD patients,
with the most severe impairments observed in the ‘‘Ac-
tivity’’ and ‘Symptom’’ sections (Figure1).
Table 3 presents results of Pearsons’ linear correlation
between FEV1 and multidimensional assessment tests.
Among COPD patients, FEV1 inversely correlated with
the MRC Dyspnoea Scale, GDS and QoL expressed byometric characteristics of COPDand controls
Controls
Mean (SD) (range) Percentile
th 25th 50th 75th
77 76.875.7 73 75 79
(65^90)
71 166.976.1 165 168 170
(156^178)
75 63.7710.2 59 65 72
(47^80)
27 24.573.8 22 24 27
(18.5^30)
TABLE 2. Meansvalues (7SD), of spirometric andhemo-
gas analitic parameters, Barthel Index, GDS, Dyspnoea
Scale (MRC) and MMSE: comparison between COPD
and controls (*Po0.05; **Po0.01)
COPD patients
(n=60)
Controls (n=58)
PaO2 (mmHg) 74.579.9** 88.7710.3
PaCO2 (mmHg) 43.274.6* 39.474.2
pH 7.470.04 7.470.03
FEV1 (l) 1.170.5** 2.270.7
FEV1% pred 48.1718.3** 98.3724.2
FEV1/VC % 47.2712.4** 74.1711.6
Barthel Index 89.7710.8** 94.274.4
GDS 5.073.9** 3.372.3
MRCDyspnoea 2.271.4** 0.570.7
MMSE 26.274.2 26.073.2
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FIG 1. Saint George Respiratory Questionnaire (SGRQ)
scores in COPD and healthy subjects. (COPD vs Controls:
**Po0.01).
TABLE 3. Pearson’s correlation coe⁄cients (r) between
FEV1 (as dependent variable) and Barthel Index, MRC
Dyspnoea Scale,GDS, SGRQ, 6MWD in COPD patients
and controls (*Po0.05; **Po0.01).
FEV1 COPD (n=60) Controls (n=58)
Barthel Index 0.37* 0.21
MRCDyspnoea Scale 0.47* 0.21
GDS 0.36** 0.21
SGRQ (Total score) 0.39** 0.07
SGRQ (Activity) 0.46** 0.03
SGRQ (Impact) 0.28* 0.13
SGRQ (Symptoms) 0.10 0.06
6MWD (m) 0.37* 0.17
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of the SGRQ. A direct relationship was found betweenFEV1, the Barthel Index and 6MWD.No correlation was
found in the control group.
Among COPD patients, the MRC Dyspnoea Scale in-
versely correlated with 6MWD distance (r: 0.51;
Po0.01), the Barthel Index (r: 0.38; Po0.01) and FEV1
(r: 0.47; Po0.01) and directly correlated with GDS (r:
0.47; Po0.01). Nevertheless, when the independent ef-
fect of single variables was tested by logistic regression
analysis, only GDS strictly predicted the degree of dys-
pnoea (OR: 1.47; 1.0^2.0; Po0.03). 6MWD correlated
with Barthel index (r: 0.55; Po0.01) in COPD patients
but not in controls. No correlation was found between
6MWD and GDS in both the groups.
In COPD patients the ‘‘Total score’’ and scores from
the ‘‘Impact’’ and ‘‘Activity’’ sections of the SGRQ signi¢-
cantly correlated with all multidimensional assessment
tests; the ‘‘Symptom’’ section showed a signi¢cant
relationship with the MRC Dyspnoea Scale and GDS
(Table 4). In normal elderly subjects, a signi¢cant correla-
tion was found only between SGRQ ‘‘Activity’’ section
and MRC score and 6MWD (Table 4).
Finally, using the logistic regression model, FEV1 was
found to be the most important factor in predicting de-
terioration of QoL in COPD patients (OR: 14.0; 95% CI:
3.6^54.9); by thismodel,QoLwas also slightly in£uenced
byGDS (OR:1.3) and Barthel Index (OR:1.02) while Dys-
pnoea Scale and 6MWDresulted not signi¢cant.
DISCUSSION
Because elderlypatients a¡ectedwithCOPD-relatedre-
spiratory involvement are frequently impaired in their
social life, psychological function and ADL, it is impor-
tant to establish the relationship between COPD and
QoL in this population.The aim of our study was to in-
vestigate the impact of COPD on QoL and functional
status in the elderly.
As expected, our COPD patients showed a signi¢cant
reduction in lung volume compared to healthy controls;
they were nevertheless normoxaemic and normocapnic
at rest. This observation can be explained by the fact
that the inability to perform the 6MWD was an exclu-
sion criterion.
During sleep, elderly COPD patients were signi¢-
cantlymore hypoxaemic than controls.Given that blood
gas exchange deterioration during night-time in adult pa-
tients with COPD is a well-known factor that worsens
quality of sleep and daytime functional status (8,18), we
can argue that even in older subjects with chronic ob-
structive lungdisease the deterioration of functional sta-
tusmay at least in part be related to nocturnal blood gas
derangement and not only to age itself.
The distancewalkedduring 6MWDbyCOPDpatients
was signi¢cantly shorter than the controls’; in addition,
among COPD patients this distance inversely correlated
TABLE 4. Pearson’s correlation coe⁄cients (r) between SGRQ and Barthel Index, MRC Dyspnoea Scale,GDS, 6MWD in
COPD patients andhealthy subjects (*Po0.05;**Po0.01).
Barthel Index MRCDyspnoea scale GDS 6MWD
COPD Controls COPD Controls COPD Controls COPD Controls
SGRQ (Total score) 0.48** 0.03 0.41** 0.39 0.53** 0.07 0.39** 0.25
SGRQ (Activity) 0.43** 0.06 0.47** 0.44* 0.52** 0.16 0.36**  0.34*
SGRQ (Symptoms) 0.12 0.14 0.34* 0.33 0.43** 0.001 0.49 0.15
SGRQ (Impact) 0.50** 0.03 0.34* 0.32 0.48** 0.07 0.37**  0.18
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pact’’ components. According to other reports, these
data con¢rm that COPDmay reduce exercise tolerance
and daily activities even in older patients (19, 20).
Dyspnoea is considered a reliable index of disability
and the main factor in£uencing exercise tolerance and
QoL in COPD patients (21, 22). Nevertheless, multivari-
ate analysis of our elderly patients’data excluded a signif-
icant in£uence of dyspnoea, as expressed by MRC
Dyspnoea Scale, on 6MWD and SGRQ. In addition, the
degree of dyspnoea did not correlate with lung volume
deterioration, thus con¢rming that the severity of this
symptom is not strictly in£uenced by the degree of air-
way obstruction. In agreement with previous studies
(23, 24), our results show that dyspnoea may be in£u-
enced by emotional and mood components. However,
the relationship between this symptom and depression
still remains unclear: in fact, although we could argue
that older subjects with a depressed mood tend to em-
phasize dyspnoea, we could also conclude that a dys-
pnoeic patient tends to be more depressed due to his
functional restriction.
An additional problem could rise by the observation
that also in the control group there is a signi¢cant corre-
lation between SGRQ ‘‘Activity’’ section,MRCDyspnoea
Scale and 6MWD: this may suggest that some items ex-
amined by SGRQ may be in£uenced not only by the de-
gree of COPD but also by the coexistence of age-related
functional impairment.
Previous studies aimed at investigating the impact of
obstructive ventilatory impairment on QoL in the el-
derly yielded controversial results: some authors
(25, 26) demonstrated an improvement of QoL with age
in COPD patients, presumably related to the fact that
older subjects usually tend to restrict their own daily ac-
tivity and expectations. In contrast, others suggest a
persisting disease-related deterioration of QoL in older
COPDpatients (27). In our study, SGRQ scoreswere sig-
ni¢cantly higher for subjects with COPD, thus con¢rm-
ing that the e¡ect of the disease onQoL persists even at
an advanced age; according to other studies (28) the im-
pact of airway obstruction on QoL is demonstrated
by the signi¢cant relationship between FEV1 and SGRQ(Table 3) and con¢rmed by the logistic regression analy-
sis. Nevertheless, mood seems to in£uence not only
respiratory symptoms but also QoL, thus con¢rming
previous observation (29).
In conclusion, our ¢ndings suggest that COPD is a
main cause of severe deterioration of QoL, physical ac-
tivity and functional status in elderly populations and
that the degree of this impairment mainly depends on
the severity of chronic airway obstruction, although it
may be aggravated bymood de£ection.
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